| 1405 |
National Cancer Institute |
Html |
en |
Cervical Cancer Prevention (PDQ®)–Patient Version |
Expert-reviewed information summary about factors that may increase the risk of developing cervical cancer and about approaches that may help in the prevention of this disease. |
| PDQ Screening | 0.395266 |
| cancer risk factors | 0.465043 |
| oral contraceptives | 0.438033 |
| cancer treatment | 0.390982 |
| Cancer prevention | 0.619043 |
| cancer prevention trials | 0.470767 |
| abnormal cervical cells | 0.463053 |
| cancer protective factor | 0.439823 |
| prevention clinical trials | 0.438965 |
| cancer cells | 0.400997 |
| protective factors | 0.455926 |
| HPV types | 0.411037 |
| HPV vaccine | 0.401428 |
| following PDQ summaries | 0.448435 |
| Cancer Information Service | 0.430288 |
| PDQ cancer information | 0.630431 |
| invasive cervical cancer | 0.504514 |
| Clinical Trials section | 0.393195 |
| Prevention Editorial Board | 0.439371 |
| treatment clinical trials | 0.393798 |
| National Cancer Institute | 0.521385 |
| clinical trials | 0.611046 |
| PDQ documents | 0.395997 |
| cancer information summary | 0.515615 |
|
| new treatment | 0.398221 |
| risk factors | 0.555011 |
| breast cancer prevention | 0.420054 |
| cancer forms | 0.395987 |
| Cancer Care page | 0.41723 |
| PDQ database | 0.400536 |
| cervical cancers | 0.417709 |
| cancer risk factor | 0.465684 |
| cervical cancer | 0.971358 |
| NCI’s PDQ | 0.407193 |
| PDQ summary | 0.474187 |
| HPV DNA test | 0.436876 |
| cervical tissue | 0.4228 |
| HPV infection | 0.691233 |
| NCI PDQ cancer | 0.484698 |
| cervical cancer returns | 0.505886 |
| cancer clinical trials | 0.44162 |
| HPV vaccines | 0.42638 |
| cervical cancer prevention | 0.606362 |
| cancer information summaries | 0.438481 |
| cervical dysplasia | 0.459221 |
| comprehensive cancer information | 0.437982 |
| Cervical Cancer Screening | 0.500339 |
|
CLICK HERE |
| 1479 |
National Cancer Institute |
Html |
en |
Prostate Cancer Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of prostate cancer. |
| prostate cancer warrants | 0.499797 |
| screen-detected prostate cancer | 0.525488 |
| grade prostate cancer | 0.523426 |
| Low-Risk Prostate Cancer | 0.500547 |
| Engl J Med | 0.559367 |
| advanced prostate cancer | 0.529012 |
| prostate cancer treatment | 0.512803 |
| Prostate Cancer Prostatic | 0.498893 |
| clinically localized prostate | 0.673086 |
| Int J Radiat | 0.493888 |
| metastatic prostate cancer | 0.500485 |
| Radiat Oncol Biol | 0.568418 |
| prostate cancer increases | 0.499539 |
| prostate specific antigen | 0.536475 |
| Natl Cancer Inst | 0.689089 |
| organ-confined prostate cancer | 0.499295 |
| radiation therapy | 0.50488 |
| Prostate cancer diagnosis | 0.525315 |
| prostate carcinoma | 0.533902 |
| et al. | 0.579019 |
| nonpalpable prostate cancer | 0.508262 |
| National Prostate Cancer | 0.512122 |
| Prostate Cancer section | 0.509753 |
| Prostate Cancer Outcomes | 0.519033 |
| recurrent prostate cancer | 0.502138 |
|
| castration-resistant prostate cancer | 0.500277 |
| prostate cancer eligible | 0.506835 |
| Prostate Cancer Intervention | 0.504501 |
| Prostate cancer radiation | 0.50507 |
| PUBMED Abstract | 0.502954 |
| radical prostatectomy | 0.797797 |
| Localized Prostate Cancer | 0.557914 |
| early prostate cancer | 0.559358 |
| Castration-Sensitive Prostate Cancer | 0.498217 |
| low grade prostate | 0.495809 |
| localised prostate cancer | 0.501262 |
| radical retropubic prostatectomy | 0.495282 |
| Abstract | 0.672665 |
| Clin Oncol | 0.580989 |
| Oncol Biol Phys | 0.571819 |
| prostate cancer prognosis | 0.512411 |
| Prostate Cancer Register | 0.511523 |
| prostate cancer survival | 0.523146 |
| risk prostate cancer | 0.510212 |
| prostate cancer | 0.923001 |
| Association Prostate Cancer | 0.506382 |
| prostate cancer progression | 0.524034 |
| prostate cancer recurrence | 0.538252 |
| watchful waiting | 0.496685 |
|
CLICK HERE |
| 1502 |
National Cancer Institute |
Html |
null |
Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of childhood soft tissue sarcomas. |
|
|
CLICK HERE |
| 1521 |
National Cancer Institute |
Html |
en |
Cervical Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of cervical cancer. |
| IVA cervical cancer | 0.494515 |
| cervical cancer spreads | 0.502418 |
| body | 0.528161 |
| type | 0.484435 |
| Early cervical cancer | 0.515203 |
| PDQ cancer information | 0.510772 |
| clinical trial search | 0.530123 |
| clinical trials | 0.780834 |
| cancer information summary | 0.492424 |
| clinical trial | 0.63691 |
| IA cervical cancer | 0.494652 |
| vagina | 0.476362 |
| cervical cancer | 0.932453 |
| cervical tissue | 0.475608 |
| NCI PDQ cancer | 0.471306 |
| malignant tumor cells | 0.469474 |
| Treatment Option Overview | 0.483839 |
| lymph nodes | 0.584318 |
| radiation therapy | 0.643883 |
| Cervical Cancer Screening | 0.51612 |
| General information | 0.472784 |
| general cancer information | 0.468618 |
| treatment | 0.635154 |
| abnormal cells | 0.496903 |
| cervical cone biopsy | 0.469689 |
|
| cervical canal | 0.468388 |
| NCI-supported cancer | 0.488984 |
| cancer cells | 0.615466 |
| Cancer Information Service | 0.469545 |
| specific cancer cells | 0.475327 |
| Option Overview section | 0.476093 |
| IIA cervical cancer | 0.495532 |
| Recurrent cervical cancer | 0.57997 |
| treatment clinical trials | 0.483221 |
| cervical cancer stage | 0.518375 |
| National Cancer Institute | 0.533825 |
| cervix | 0.572702 |
| new treatment | 0.480833 |
| Cervical Cancer Prevention | 0.516533 |
| IVB cervical cancer | 0.494429 |
| procedure | 0.476082 |
| cancer clinical trials | 0.543686 |
| stage | 0.613195 |
| tumor | 0.505161 |
| cancer information summaries | 0.471295 |
| pelvic wall | 0.470332 |
| internal radiation therapy | 0.527167 |
| Cervical Cancer Treatment | 0.509501 |
| cancer | 0.952499 |
|
CLICK HERE |
| 1566 |
National Cancer Institute |
Html |
en |
Lung Cancer Screening (PDQ®)–Patient Version |
Expert-reviewed information summary about tests used to detect or screen for lung cancer. |
| cancer treatment | 0.392038 |
| cancer screening methods | 0.488117 |
| lung cancer screening | 0.581106 |
| sputum cytology | 0.454434 |
| helical CT screening | 0.431007 |
| following PDQ summaries | 0.451695 |
| PDQ cancer information | 0.634342 |
| lung cancer | 0.990038 |
| clinical trials | 0.54732 |
| early-stage lung cancer | 0.49565 |
| Lung Screening Trial | 0.507741 |
| test result | 0.457525 |
| cancer information summary | 0.516813 |
| clinical trial | 0.403293 |
| small cell lung | 0.453619 |
| left lung | 0.419389 |
| breast cancer prevention | 0.412831 |
| diagnostic tests | 0.395868 |
| latest published information | 0.391467 |
| chest x-rays | 0.422818 |
| NCI’s PDQ | 0.406959 |
| cancer symptoms | 0.405957 |
| NCI PDQ cancer | 0.483096 |
| PDQ Screening | 0.452902 |
|
| low-dose helical CT | 0.462904 |
| Lung Cancer Prevention | 0.505332 |
| right lung | 0.42299 |
| cancer cells | 0.390233 |
| following screening tests | 0.445615 |
| spiral CT scans | 0.438882 |
| Cancer Information Service | 0.430519 |
| Prevention Editorial Board | 0.438477 |
| National Cancer Institute | 0.525164 |
| Cancer Screening Overview | 0.474654 |
| PDQ documents | 0.398876 |
| cancer death | 0.395593 |
| new treatment | 0.3913 |
| Cancer screening trials | 0.493779 |
| Cancer Care page | 0.417222 |
| PDQ database | 0.403172 |
| Low-dose spiral CT | 0.541598 |
| non-small cell lung | 0.454698 |
| PDQ summary | 0.523845 |
| cell lung cancer | 0.537709 |
| cancer information summaries | 0.438235 |
| comprehensive cancer information | 0.437914 |
| non-skin cancer | 0.39574 |
| chest x-ray | 0.418575 |
|
CLICK HERE |
| 1803 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de colon (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de colon. |
| Surgical Adjuvant Breast | 0.408847 |
| adjuvant chemotherapy | 0.410347 |
| non-metastatic colon | 0.414428 |
| Adults With Colorectal | 0.413355 |
| stage t4 colon | 0.415683 |
| locally advanced colon | 0.41442 |
| National Comprehensive Cancer | 0.414021 |
| American Society | 0.415077 |
| Study Group | 0.41129 |
| ensayo cancer | 0.415058 |
| Cancer Res | 0.41418 |
| Nelson H | 0.408583 |
| Radiat Oncol Biol | 0.414458 |
| colorectal cancer | 0.940744 |
| adjuvant therapy | 0.414593 |
| Natl Cancer Inst | 0.446315 |
| after curative resection | 0.408289 |
| with resected colon | 0.417545 |
| oxaliplatino capecitabina | 0.40883 |
| nonpolyposis colorectal carcinoma | 0.413444 |
| patients with | 0.47987 |
| Clinical Oncology | 0.42334 |
| colon nombre | 0.415112 |
| laparoscopic colon surgery | 0.427077 |
| CLA vs | 0.408768 |
|
| b2 colon cancer | 0.44357 |
| Dis Colon Rectum | 0.558033 |
| following laparoscopic-assisted | 0.410031 |
| Localized colon | 0.415631 |
| clinical outcomes | 0.414174 |
| 5-fu irinotecán | 0.410365 |
| Hereditary Cancer Syndromes | 0.413975 |
| patients with stage | 0.419991 |
| conventional colorectal resections | 0.419013 |
| Cancer Prevention Study | 0.415267 |
| colon cancer | 0.765585 |
| colon tumors | 0.415991 |
| Clin Oncol | 0.64523 |
| Oncol Biol Phys | 0.414687 |
| colorectal carcinoma | 0.429559 |
| 5-fu oxaliplatino | 0.41833 |
| estadio iii | 0.410102 |
| high-risk colon carcinoma | 0.415916 |
| surgical adjuvant | 0.409066 |
| American Joint Committee | 0.411047 |
| with colorectal cancer | 0.469671 |
| Colon Cancer Trials | 0.426531 |
| National Surgical Adjuvant | 0.40852 |
| Clinical Oncology colorectal | 0.413685 |
|
CLICK HERE |
| 2019 |
National Cancer Institute |
Html |
es |
Exámenes de detección del cáncer de cuello uterino (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca de las pruebas utilizadas para detectar o de los exámenes detección sistemática el cáncer de cuello uterino. |
| Obstet Gynecol | 0.418098 |
| cervical carcinoma | 0.403783 |
| mujeres frente | 0.403728 |
| squamous cells | 0.404736 |
| American Cancer Society | 0.40494 |
| lesion triage study | 0.403147 |
| case-control study | 0.405788 |
| cervical screening | 0.4086 |
| cervical neoplasia | 0.409268 |
| Schiffman M | 0.402549 |
| Triage Study | 0.405541 |
| Natural history | 0.403957 |
| Preventive Services Task | 0.402237 |
| citologÃa cervical simultáneas | 0.405826 |
| mild cervical dysplasia | 0.403858 |
| VPH carcinógenas | 0.40547 |
| Estados Unidos | 0.417275 |
| prueba pap | 0.411293 |
| Natl Cancer Inst | 0.410724 |
| cervical cancer | 0.523614 |
| papillomavirus infection | 0.403088 |
| única prueba | 0.403224 |
| human papillomavirus | 0.418921 |
| Cuello C | 0.403028 |
| atypical squamous cells | 0.40277 |
|
| SEER Cancer Statistics | 0.402517 |
| squamous intraepithelial lesion | 0.405593 |
| Kulasingam SL | 0.40266 |
| cervical cytology | 0.415384 |
| Cancer Facts | 0.402516 |
| lesiones nic | 0.408608 |
| VPH solas | 0.405319 |
| Pap periódicas | 0.403922 |
| abnormal screening papanicolaou | 0.402215 |
| cervical screening with | 0.406225 |
| National Cancer Institute | 0.402517 |
| Intern Med | 0.403466 |
| cervical smears | 0.405667 |
| Services Task Force | 0.402151 |
| intraepithelial lesion triage | 0.402447 |
| cervical intraepithelial neoplasia | 0.406913 |
| cuello uterino | 0.992428 |
| invasivo exhiben pruebas | 0.402524 |
| cervical cytologic | 0.405907 |
| cervical squamous | 0.403914 |
| mujeres morirán | 0.404155 |
| prueba iva | 0.403005 |
| mujeres jóvenes | 0.420213 |
| Cervical Cancer Early | 0.406229 |
|
CLICK HERE |
| 3456 |
National Cancer Institute |
Html |
es |
Acupuntura (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos sobre la acupuntura como tratamiento para las personas con cáncer o trastornos relacionados con esta enfermedad. |
| acupuntura forma | 0.644774 |
| Centro Nacional | 0.425173 |
| causa reacciones | 0.422733 |
| New Hampshire Avenue | 0.41766 |
| acupuntos correctos | 0.426568 |
| causa hinchazón | 0.417784 |
| Drug Administration | 0.410869 |
| neuropatÃa periférica | 0.548649 |
| NCI Best Case | 0.428652 |
| datos bibliográficos pubmed | 0.418907 |
| largo plazo | 0.414083 |
| National Cancer Institute | 0.420958 |
| siglo xviii | 0.41833 |
| siguientes riesgos | 0.413128 |
| PDQ Acupuntura | 0.568448 |
| acupuntura ayuda | 0.53948 |
| Instituto Nacional | 0.496395 |
| numerosos informes | 0.41497 |
| National Certification Commission | 0.424144 |
| Salud Complementaria | 0.436282 |
| Visuals Online | 0.412814 |
|
| náuseas matutinas | 0.436773 |
| mamaEl linfedema | 0.418357 |
| complementarias revisa | 0.41658 |
| sistema nervioso central | 0.511178 |
| Physician Data Query | 0.473664 |
| Medicina Oriental | 0.41709 |
| Estados Unidos | 0.901304 |
| Comisión Nacional | 0.410413 |
| libre uso | 0.418723 |
| Oriental Medicine | 0.412484 |
| distintos resultados | 0.413109 |
| cabo estudios | 0.47129 |
| piel agujas | 0.436066 |
| página manejo | 0.412054 |
| ¿El tratamiento | 0.424697 |
| ¿Los beneficios | 0.410887 |
| juntos cam | 0.410417 |
| qi causa dolor | 0.459263 |
| Series Program | 0.410794 |
| medicina complementaria | 0.788071 |
| Institutos Nacionales | 0.521236 |
|
CLICK HERE |
| 3575 |
National Cancer Institute |
Html |
en |
NCI’s Role in Cancer Research |
When people think about cancer research, they may envision men and women in lab coats, carefully dripping substances into test tubes or peering thoughtfully into microscopes. Of course, those things do happen in biomedical research. But they are just one small part of a much larger research landscape. |
| larger research landscape | 0.406002 |
| research projects | 0.473958 |
| ongoing research projects | 0.366171 |
| NCI’s research | 0.415082 |
| clinical trials | 0.909263 |
| translational research | 0.434177 |
| Cancer Informatics Program | 0.357576 |
| NCI leadership | 0.366577 |
| NCI funding | 0.344193 |
| NCI’s budget | 0.341097 |
| basic research questions | 0.406498 |
| specific research areas | 0.376759 |
| late-phase clinical trials | 0.337365 |
| cancer research study | 0.479905 |
| cancer research studies | 0.541646 |
| private sector | 0.396556 |
| NCI’s divisions | 0.382718 |
| NCI’s mission | 0.342763 |
| NCI | 0.563137 |
| clinical research | 0.358682 |
| population-based research | 0.407311 |
| NCI intramural program | 0.395461 |
| NCI senior leadership | 0.384992 |
| cancer research continuum | 0.462835 |
| advisory boards | 0.398662 |
|
| new cancer treatments | 0.407593 |
| implementation research | 0.334824 |
| cancer cells | 0.456417 |
| pediatric cancer survivors | 0.362759 |
| cancer research | 0.981446 |
| new cancer research | 0.494493 |
| Later-phase clinical trials | 0.343846 |
| NCI review | 0.341394 |
| earlier research | 0.344026 |
| different cancer types | 0.386961 |
| NCI conducts | 0.339869 |
| cancer outcomes | 0.342815 |
| NCI program offices | 0.431082 |
| health care | 0.339118 |
| cancer researchers | 0.448005 |
| new treatment | 0.465207 |
| NCI staff | 0.45834 |
| important research projects | 0.386667 |
| Cancer Genome Atlas | 0.377483 |
| biomedical research | 0.393005 |
| cancer risk | 0.371733 |
| research programs | 0.395973 |
| cancer biology | 0.366782 |
| basic research | 0.65541 |
|
CLICK HERE |
| 16711 |
National Cancer Institute |
Html |
null |
Iniciativa de Respuestas Excepcionales: Preguntas y respuestas |
El Instituto Nacional del Cáncer (NCI) emprendió la Iniciativa de Respuestas Excepcionales a fin de entender la base molecular de los tumores en pacientes de cáncer que responden en forma excepcional al tratamiento, principalmente quimioterapia. |
|
|
CLICK HERE |